Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002917675 | SCV003250289 | benign | Ehlers-Danlos syndrome, classic type, 1 | 2022-04-07 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003167903 | SCV003912711 | uncertain significance | Familial thoracic aortic aneurysm and aortic dissection | 2023-02-01 | criteria provided, single submitter | clinical testing | The p.R956Q variant (also known as c.2867G>A), located in coding exon 42 of the COL5A2 gene, results from a G to A substitution at nucleotide position 2867. The arginine at codon 956 is replaced by glutamine, an amino acid with highly similar properties. This amino acid position is well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Prevention |
RCV003434517 | SCV004118591 | uncertain significance | COL5A2-related disorder | 2023-01-25 | criteria provided, single submitter | clinical testing | The COL5A2 c.2867G>A variant is predicted to result in the amino acid substitution p.Arg956Gln. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.012% of alleles in individuals of African descent in gnomAD (http://gnomad.broadinstitute.org/variant/2-189916110-C-T). Although we suspect that this variant may be benign, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |
ARUP Laboratories, |
RCV003759764 | SCV004563545 | likely benign | Ehlers-Danlos syndrome, classic type, 2 | 2023-11-10 | criteria provided, single submitter | clinical testing |